| Product NDC: | 54859-504 |
| Proprietary Name: | Orasep |
| Non Proprietary Name: | Benzocaine, Menthol, Cetylpyridinium Chloride |
| Active Ingredient(s): | 2; .1; .5 mL/100mL; mL/100mL; mL/100mL & nbsp; Benzocaine, Menthol, Cetylpyridinium Chloride |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 54859-504 |
| Labeler Name: | Llorens Pharmaceutical International Division |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part346 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100401 |
| Package NDC: | 54859-504-01 |
| Package Description: | 30 mL in 1 BOTTLE, SPRAY (54859-504-01) |
| NDC Code | 54859-504-01 |
| Proprietary Name | Orasep |
| Package Description | 30 mL in 1 BOTTLE, SPRAY (54859-504-01) |
| Product NDC | 54859-504 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Benzocaine, Menthol, Cetylpyridinium Chloride |
| Dosage Form Name | LIQUID |
| Route Name | TOPICAL |
| Start Marketing Date | 20100401 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Llorens Pharmaceutical International Division |
| Substance Name | BENZOCAINE; CETYLPYRIDINIUM CHLORIDE; MENTHOL |
| Strength Number | 2; .1; .5 |
| Strength Unit | mL/100mL; mL/100mL; mL/100mL |
| Pharmaceutical Classes |